Design optimization of a novel pMDI actuator for systemic drug delivery

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 20, Issue 4, 2007, Pages 460-474

  Kakade, Prashant P ^a   Versteeg, Henk K ^b   Hargrave, Graham K ^b   Genova, Perry ^a   Williams III, Robert C ^a   Deaton, Daniel ^a  

^a Kos Pharmaceuticals Inc   (United States)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Actuator design; Metered dose inhaler; Optical diagnostics; Phase Doppler anemometry; Systemic drug delivery

Indexed keywords

FLUTICASONE PROPIONATE; NORFLURANE; POLY(METHYL METHACRYLATE); SALBUTAMOL;

AEROSOL; ANEMOMETRY; ARTICLE; EQUIPMENT DESIGN; EVALUATION; GEOMETRY; LASER; METERED DOSE INHALER; OROPHARYNX; PERFORMANCE; PLUME DISPERSION; THROAT; VELOCITY; VORTEX MOTION; VORTEX NOZZLE ACTUATOR;

ADMINISTRATION, INHALATION; AEROSOLS; EQUIPMENT DESIGN; HUMANS; METERED DOSE INHALERS;

EID: 37549011360     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2007.0595     Document Type: Article

References (24)

1. Fink, J.B. 2000. Metered dose inhalers, dry powder inhalers, and transitions. Respiratory Care, Vol. 45, pp. 623-635.
2. Newman S. 2005. Principles of metered-dose inhalers. Respir. Care 50:1177-1190.
3. Saurez, S., and A. Hickey. 2000. Drug properties affecting aerosol behavior. Respir. Care 45:652-666.
4. Smyth, H.D.C. 2003. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv. Drug Del. Rev. 55:807-828.
5. Barry, P.W., and C. O'Callaghan. 2003. The influence of inhaler selection on the efficacy of asthma therapies. Adv. Drug Deliv. Rev. 55:879-923.
6. Dolovich, M.B., R.C. Ahrens, D.R. Hess, P. Anderson, R. Dhand, J.L. Rau, G.L. Smaldone, and G. Guyatt. 2005. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127:335-371.
7. Genova, P.A., R.C. Williams III, W. Jewett. 2002. Low spray force, low retention atomization system. US Patent 6,418,925.
8. th Biennial Conference on Engineering Systems Design & Analysis, July 19-22 2004, Manchester, UK.
9. Food and Drug Administration. Draft Guidance for Industry on Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products," Chemistry, Manufacturing and Controls Documentation; Sections IV.B.12. and IV.B.14. Washington, DC: U.S. FDA.
10. Gabrio, B.J., S.W. Stein, and D.J. Velasquez. 1999. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int. J. Pharmaceut. 186:3-12.
11. Dantec Product literature for Particle Dynamics Analysis/Phase Doppler Anemometry technique. Available at: http://www.dantecdynamics.com/PDA/System
12. Dunbar, C.A. 1996. An experimental and theoretical investigation of the spray issued from a pMDI. PhD Thesis, UMIST, Manchester, UK.
13. Dunbar, C.A., A.P. Watkins, and J.F. Miller. 1997. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J. Aerosol Med. 10:351-368.
14. Wigley, G., H.K. Versteeg, and D. Hodson. 2002. Near-orifice PDA measurements and atomisation mechanism of a pharmaceutical pressurised metered dose inhaler. Proceedings of the 18th Annual Conference on Liquid Atomization & Spray Systems, Zaragoza, Spain, 9-11 September, 2002, pp. 165-170.
15. Versteeg, H.K., G.K. Hargrave, P.A. Genova, and I.M. Schmalfuss. 2004. Optical and MRI imaging - their use in actuator design for improved drug delivery. Proceeding of Respiratory Drug Delivery IX Conference, pp. 211-219.
16. Finlay, W.H., W. DeHaan, B. Grgic, A. Heenan, E.A. Matilda, M. Hoskinson, A. Pollard, C.F. Lange. 2002. Fluid mechanics and particle deposition in the oropharynx: the factors that really matter. Proc. of Respir. Drug Deliv. VIII:171-177.
17. Dolovich, M. 1999. New delivery systems and propellants. Can. Respir. J. 6:290-295.
18. Stein, S.W., and J.S. Stefely. 2003. Reinventing metered dose inhalers: from poorly efficient CFC MDIs to highly efficient HFA MDIs. Drug Deliv. Technol. 3:46-51.
19. Smyth, H.D.C., and A.J. Hickey. 2003. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered dose inhalers. AAPS Pharmaceu. Sci. Technol. 4:38.
20. Priestman, G.H. 1987. A study of vortex throttles - Part 1 experimental. Proceedings of the Institution of Mechanical Engineers, Vol. 201, No. C5, pp. 331-336.
21. Smyth, H.D.C., Brace G., Barbour T., Gallion J., Grove J., Hickey A.J. 2006. Actuator design variables for particle size modulation. Proceedings of Respiratory Drug Delivery X, Vol. 3, pp. 857-860.
22. Smyth, H.D.C., G. Brace, T. Barbour, J. Gallion, J. Grove, A.J. Hickey. 2006. Influence of actuator design on spray pattern analysis of metered dose inhalers. Proceedings of Respiratory Drug Delivery X Conference, Vol. 3, pp. 861-863.
23. Taniere, R., J.S. de Groot, S. Gray, S. White, J.M. Parker, and N.J. Harper. 2006 Exubera® Insulin pulmonary inhaler performance: a demonstration of robustness using simulated use and misuse scenarios. Proceedings of Respiratory Drug Delivery X Conference, pp. 703-707.
24. Finlay, W.H. 2001. The Mechanics of Inhaled Pharmaceutical Aerosols. Academic Press, San Diego.